# China NMPA Inspection - Anyang Meizhilin Biotechnology Co., Ltd. - December 05, 2017

Source: https://www.globalkeysolutions.net/records/china_inspection/anyang-meizhilin-biotechnology-co-ltd/bc2a8eca-41f9-4620-9fbe-ea7f2a6e435f/
Source feed: China

> China NMPA unannounced inspection for Anyang Meizhilin Biotechnology Co., Ltd. published December 05, 2017. An unannounced FDA NMPA inspection on November 5, 2017, at Anyang Meizhilin Biotechnology Co., Ltd. identified significant compliance breaches in cosm

---

## Details

- Record Type: CHINA_INSPECTION
- Title: Forwarding the notification from the Henan Provincial Food and Drug Administration regarding the unannounced inspection of Anyang Meizhilin Biotechnology Co., Ltd.
- Company Name: Anyang Meizhilin Biotechnology Co., Ltd.
- Publication Date: 2017-12-05
- Product Type: Cosmetics
- Summary: An unannounced FDA NMPA inspection on November 5, 2017, at Anyang Meizhilin Biotechnology Co., Ltd. identified significant compliance breaches in cosmetic manufacturing. The inspection revealed multiple violations of Good Manufacturing Practices (GMP) and product control regulations. Critical issues included a lack of environmental monitoring plans and routine monitoring for the Class 300,000 cleanroom, absence of status indicators on weighing equipment, and inadequate temperature and humidity control in the raw material warehouse. The company also failed to maintain essential documentation, such as operation, cleaning, and maintenance records for crucial equipment, and exhibited poor hygiene in changing rooms and production areas. Furthermore, substantial problems existed with product and material traceability. Semi-finished products lacked proper status labels, production records, and registration. Several cosmetic products, both sold and in inventory, had no corresponding batch production or inspection records, retained samples, or a finished product inventory ledger. The company could not provide purchase invoices for specific raw materials or maintain a raw material inventory ledger. Consequently, Anyang Meizhilin Biotechnology Co., Ltd. was ordered to rectify all identified deficiencies, and the case has been transferred to the Anyang Municipal Bureau for further investigation and legal action.

Company: https://www.globalkeysolutions.net/companies/anyang-meizhilin-biotechnology-co-ltd/630b4989-e5a5-43a5-80b8-cca13050e879/